Shweta Joshi

3PUBLICATIONS
13CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 12, 2023
Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.

Deepak Rohila, In Hwan Park, Timothy V Pham

|Mar 06, 2021
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma.

Mehreen Ishfaq, Timothy Pham, Cooper Beaman

|Mar 12, 2019
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System.

Shweta Joshi, Donald L Durden

Pageof 1

Frequent Collaborators

2 joint publications

Cooper Beaman

1 joint publications

Deepak Rohila

1 joint publications

In Hwan Park

1 joint publications

Timothy V Pham